Free Trial

Market Wrap

CREDIT UPDATE


  • Bunds are sitting 4-5bps cheaper at most benchmark maturities – our DM team note the low volumes and quiet macro calendar though see some support for the wider FI space from the fall in Brent futures at -1% DoD.
  • Main/XO are sitting 1.5bp/10bp tighter with compression now back to 260bp and Main flat to the year-end level of 58bp. FICM is showing €IG/€HY +0.8bp/-4bp with Sub Fins outperforming within €IG (flat DoD).
  • SXXP is +0.2% - Healthcare and Tech are the two sectors in the red at -0.5% each, with Zealand Pharma selling-off by a further 5% in the wake of last week’s Eli Lilly obesity drug trial results while the tech decline appears more broad-based.
116 words

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.


  • Bunds are sitting 4-5bps cheaper at most benchmark maturities – our DM team note the low volumes and quiet macro calendar though see some support for the wider FI space from the fall in Brent futures at -1% DoD.
  • Main/XO are sitting 1.5bp/10bp tighter with compression now back to 260bp and Main flat to the year-end level of 58bp. FICM is showing €IG/€HY +0.8bp/-4bp with Sub Fins outperforming within €IG (flat DoD).
  • SXXP is +0.2% - Healthcare and Tech are the two sectors in the red at -0.5% each, with Zealand Pharma selling-off by a further 5% in the wake of last week’s Eli Lilly obesity drug trial results while the tech decline appears more broad-based.